The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases
Clinical trial NCT04397107 · COMPLETED
Trial details
- NCT number
- NCT04397107
- Sponsor
- The First Hospital of Jilin University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-15
- Primary completion
- 2022-05-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.